date:Apr 29, 2014
significant adverse currency effects and an increase of 2.4 million to 7.3 million in RD costs in Q1 versus Q1 2013, said Gerard Hoetmer, CEO. Trading performance was mixed across our different markets: Biobased Food Ingredients volumes declined slightly, below our expectations, particularly in North America. On the other hand, Biochemicals continued its very good and broad-based performance, growing organically by 17%.
The company said that Q1 2014 was a challenging quarter for Biobased Food